Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
doi: 10.1139/o71-037 10 BrownJCMuttVPedersonRA
Now, I can have a piece of pizza and be full, as opposed to eating two and a half pieces, Erica says
About the study In the present study, researchers assessed the presence of semaglutide in breast milk
As of 2025, retatrutide remains under investigation and has not yet received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
Its caused by a combination of age, genetics, and hormones